A subsidiary of a San Antonio drug development company, Evestra, Inc.,has won a major grant to finance the development of a drug to treat endometriosis.
The European Union Regional Development Fund awarded Evestra Onkoligia Sp.in Poland $4.6 million dollars.
Endometriosis is a common female health problem that affects about 10 percent of women, causing pain and sometimes infertility.
Evestra, Inc. is a pharmaceutical research company that focuses on women’s health.
